PE/VC  NMT Capital

http://www.nmtcapital.com





     Office Locations:

175 Washington Street
Norwell, MA 02061
Phone: 617-472-2805
Fax: 617-472-3531

Get all office locations for this firm with a National Database subscription.
 

Stages:

  • Early
  • Growth


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    NMT Capital (formerly Nexus) is a globally oriented private equity firm. It is currently managing three investment funds: two based in Europe and one in the U.S., and its portfolio companies are located in both continents. They are carefully selected from among a wide universe of potential investment opportunities to possess the best technology or business strategy available globally. Founded in 2004 as Nexus Medical Partners, Nexus has expanded its investment strategy to include IT investments as well. It is managed by three Principals who are supported by Advisors and affiliates in Norwell (MA), San Francisco, London, Munich, Geneva and Tokyo. The Principals of Nexus have experience investing in companies in various stages of development, across sectors including medical devices, diagnostics, biotechnology, specialty pharmaceutical, drug discovery tools, software, communications and information technology and advanced materials. The firm is active globally and will consider not only domestic investments, but also offshore (ex-US) investments in companies located in Europe and the Middle East who are seeking to penetrate the U.S. market. The Nexus team members have managed assets valued at over $1 billion.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Edwin Snape Ph.D. Co-Founder and Senior Advisor
    Gregory F. Zaic Principal
    John F. Rousseau Co-Founder & Senior Advisor
    Thomas E. Hancock Principal

     

    Portfolio companies include:


      Kiyatec


      Lab21


      Myconostica


      MyoScience


      Neurotech


      Proterra


      Spectra Analysis Instruments


      Sultan Scientific


      Vital Sensors


      Zipit Wireless


     

    Recent News: